ConductScience.org, home

Paper17515897

Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia.

Mullican SE and 6 others. Nat Med, 2007. Cited by 278 papers, by iCite.

Cite this record

ConductScience Library. Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. Papers, record 17515897. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17515897

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia.
PubMed
Journal
Nat Med
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
278
iCite
Relative citation ratio, by iCite
5.01
iCite
Revised in PubMed
2022-03-10
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mullican SEShannon E
2Zhang SShuo
3Konopleva MMarina
4Ruvolo VVivian
5Andreeff MMichael
6Milbrandt JJeffrey
7Conneely OMOrla M

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNA-Binding ProteinsMajor topic
Leukemia, MyeloidMajor topic
Nerve Tissue ProteinsMajor topic
Receptors, Cytoplasmic and NuclearMajor topic
Receptors, SteroidMajor topic
Receptors, Thyroid HormoneMajor topic
Transcription FactorsMajor topic
Acute Disease
Animals
Blast Crisis
Down-Regulation
Humans
Mice
Mice, Inbred C57BL
Mice, Knockout
Nuclear Receptor Subfamily 4, Group A, Member 1

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA111411NCI NIH HHSUnited StatesR01CA111411PubMed and NIHNIH RePORTER
CA16672NCI NIH HHSUnited StatesP01CA016672PubMed and NIHNIH RePORTER
P01CA55164NCI NIH HHSUnited StatesP01CA055164PubMed and NIHNIH RePORTER
U19DK62434NIDDK NIH HHSUnited StatesU19DK062434PubMed and NIHNIH RePORTER
P30CA016672NIHNIH RePORTER

Download CSV of grants

Cited by194

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 278 citations.

PMIDTitleJournalYearIn PapersSource
42533114PROTAC-mediated targeting of IKKβ and NR4A1 for AML therapy.Oncogene2026https://conductscience.org/library/papers/42533114PubMed
42254657Integrated transcriptomic identification and validation reveal key autophagy-associated biomarkers in sleep deprivation.PeerJ2026https://conductscience.org/library/papers/42254657PubMed
41666265Dynamic feedback control of oncogenic tyrosine kinase signaling in acute leukemia.Sci Signal2026https://conductscience.org/library/papers/41666265PubMed
41534998Functional roles of NR4A transcription factors in GnRH regulation of gonadotropin gene expression and secretion in rat primary pituitary cells.J Reprod Dev2026https://conductscience.org/library/papers/41534998PubMed
41419000Nr4a1 β-cell specific deletion impairs glucose tolerance in female mice.Am J Physiol Endocrinol Metab2026https://conductscience.org/library/papers/41419000PubMed
41237238Blocking nuclear receptor Nr4a3 unlocks the senescence barrier to promote direct cardiac reprogramming.Sci Adv2025https://conductscience.org/library/papers/41237238PubMed
41107372NR4A1 expression aberrations contribute to radiotherapy resistance in gastric cancer.Sci Rep2025https://conductscience.org/library/papers/41107372PubMed
40666103Targeting the nuclear orphan receptor NR4A1: a key target in lung cancer progression and therapeutic resistance.Front Oncol2025https://conductscience.org/library/papers/40666103PubMed
40508074Targeting Lineage-Specific Functions of NR4A1 for Cancer Immunotherapy.Int J Mol Sci2025https://conductscience.org/library/papers/40508074PubMed
40332813Expression of Prooncogenic Nuclear Receptor 4A (NR4A)-Regulated Genes β1-Integrin and G9a Inhibited by Dual NR4A1/2 Ligands.Int J Mol Sci2025https://conductscience.org/library/papers/40332813PubMed
40114913Nuclear receptor 4A1 is critical for neutrophil-dependent pulmonary immunity to Klebsiella pneumoniae infection.Front Immunol2025https://conductscience.org/library/papers/40114913PubMed
40079203Controversy and multiple roles of the solitary nucleus receptor Nur77 in disease and physiology.FASEB J2025https://conductscience.org/library/papers/40079203PubMed
40028473Investigation methylation status of tumor suppressor gene NR4A1 and NR4A3 and frequency of rs1569686 polymorphism of DNMT3B gene in patients with acute myeloid leukemia.Mol Biol Res Commun2025https://conductscience.org/library/papers/40028473PubMed
39872303Targeting intracellular proteins with cell type-specific functions for cancer immunotherapy.Life Med2023https://conductscience.org/library/papers/39872303PubMed
39840064NR2F6 regulates stem cell hematopoiesis and myelopoiesis in mice.Front Immunol2024https://conductscience.org/library/papers/39840064PubMed
39824797Nr4a1 and Nr4a3 redundantly control clonal deletion and contribute to an anergy-like transcriptome in auto-reactive thymocytes to impose tolerance in mice.Nat Commun2025https://conductscience.org/library/papers/39824797PubMed
39589268NR4A1 and NR4A2 orphan nuclear receptors regulate endothelial-to-hematopoietic transition in mouse hematopoietic stem cell specification.Development2024https://conductscience.org/library/papers/39589268PubMed
39422036Orphan nuclear receptor NR4A1 regulates both osteoblastogenesis and adipogenesis in human mesenchymal stem cells.Mol Med Rep2025https://conductscience.org/library/papers/39422036PubMed
39417168A novel NR4A2-HuR axis promotes pancreatic cancer growth and tumorigenesis that is inhibited by NR4A2 antagonists.Am J Cancer Res2024https://conductscience.org/library/papers/39417168PubMed
39219449Loss of glucose-stimulated β-cell Nr4a1 expression impairs insulin secretion and glucose homeostasis.Am J Physiol Cell Physiol2024https://conductscience.org/library/papers/39219449PubMed

See all 194 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FASLG356PubTator's text mininghttps://conductscience.org/library/genes/356NCBI Gene
NR4A13164PubTator's text mininghttps://conductscience.org/library/genes/3164NCBI Gene
NR4A38013PubTator's text mininghttps://conductscience.org/library/genes/8013NCBI Gene
TNFSF108743PubTator's text mininghttps://conductscience.org/library/genes/8743NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17515897

GET https://conductscience.org/api/papers/v1/17515897/cited_by?page=2